Cephagenix
PrivateLast Round
Seed
Jan 15, 2025
Total Funding Raised
$9.27M
Company Overview
Cephagenix is a drug discovery company that develops novel migraine treatments by identifying and developing selective inhibitors of the ATP-sensitive potassium channel subtype expressed in intracranial arteries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cephagenix Comparables
Compare Cephagenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Slate Medicines | 78% | |
| Vedana Therapeutics | 71% | |
| H. Lundbeck A/S | 67% | |
Cephagenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 15, 2025 |
Cephagenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AbbVie Ventures | Seed |
| AdBio partners | Seed |
Cephagenix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cephagenix's valuation, stock price, and market status.